Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
WASHINGTON, Sept 29 (Reuters) - In a study likely to add to the debate over when and how often to screen for breast cancer, Swedish researchers said on Wednesday that women aged 40-49 who got regular mammograms were 29 percent less likely to die of the disease.
ZURICH (Reuters) - European healthcare regulators are reviewing the benefits of Roche's top-selling Avastin drug in breast cancer in the light of fresh clinical data, casting more uncertainty over its prospects.
CHICAGO (Reuters) - Breast cancer rates among postmenopausal women in Canada dropped nearly 10 percent after news of a big study in 2002 that found taking hormone replacement therapy could increase breast cancer risk, researchers said on Thursday.
BOSTON (Reuters) - Routine breast screening with mammograms is less effective at preventing cancer deaths than expected, Norwegian researchers said on Wednesday in a study that reignites a fierce debate over the value of screening.
LONDON (Reuters) - Scientists have found a region of DNA that can increase or decrease the high chance of breast cancer linked to a particular gene variant - a finding that could help doctors keep a closer eye on women most at risk.
CHICAGO (Reuters) - Atomic bomb blast victims lucky enough to survive one cancer have a high risk of developing a second, U.S. researchers said on Wednesday, in a study that offers new insights about cancer risks from radiation exposure.
Taking aspirin regularly may decrease risk of death from breast cancer and risk of breast cancer metastasis for women who have had early-stage breast cancer, an analysis indicates.
Three weeks of higher dose radiation worked as well as the standard-dose, five-week schedule after a lumpectomy for invasive, lymph node-negative disease, study shows.
New standards for ER, PR tests in breast cancer have been released by American Society of Clinical Oncology and College of American Pathologists.
Herceptin-based treatments without anthracyclines caused fewer cases of heart failure than treatments containing anthracyclines, study at San Antonio Symposium shows.